Innoviva, Inc. (INVA) › Cash & EquivalentsInnoviva, Inc. (INVA) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $92.28M2009: $47.54M2010: $163.33M2011: $44.78M2012: $94.85M2013: $143.51M2014: $96.80M2015: $159.18M2016: $118.02M2017: $73.34M2018: $62.42M2019: $278.10M2020: $246.49M2021: $201.53M2022: $291.05M2023: $193.51M2024: $304.96M2025: $550.94M$550.94M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$550.94M+80.7%2024$304.96M+57.6%2023$193.51M-33.5%2022$291.05M+44.4%2021$201.53M-18.2%2020$246.49M-11.4%2019$278.10M+345.5%2018$62.42M-14.9%2017$73.34M-37.9%2016$118.02M-25.9%2015$159.18M+64.4%2014$96.80M-32.5%2013$143.51M+51.3%2012$94.85M+111.8%2011$44.78M-72.6%2010$163.33M+243.5%2009$47.54M-48.5%2008$92.28M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share